Germantown, MD, United States of America

Curt Douglas Wolfgang

USPTO Granted Patents = 18 (Patent Applications = 16)

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 13 (Patent Applications = 9)

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 53(Granted Patents)

Company Filing History:

13 out of 108

Vanda Pharmaceuticals Inc.

patents

3 out of 3,539

The United States of America, As Represented by the Secretary, Department of Health and Human Services

Vanda Pharmeceuticals, Inc.

patent

Years Active: 2006-2021

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10987346 - Iloperidone for the treatment of schizophrenia (2021-04-27),

2. 10874659 - Iloperidone metabolite for use in the treatment of psychiatric disorders (2020-12-29),

3. 10563259 - Method of treatment based on polymorphisms of the KCNQ1 gene (2020-02-18),

4. 10441580 - Iloperidone for the treatment of schizophrenia (2019-10-15),

5. 10272076 - Methods for the administration of iloperidone (2019-04-30),

6. 10272075 - Method and composition for treating an alpha adrenoceptor-mediated condition (2019-04-30),

7. 9987264 - Method and composition for treating a serotonin receptor-mediated condition (2018-06-05),

8. 9446038 - Method and composition for treating a serotonin receptor-mediated condition (2016-09-20),

9. 9157121 - Method of treatment based on polymorphisms of the KCNQ1 gene (2015-10-13),

10. 9138432 - Methods for the administration of iloperidone (2015-09-22),

11. 8999638 - Method of treatment based on polymorphisms of the KCNQ1 gene (2015-04-07),

12. 8729100 - Method and composition for treating an alpha adrenoceptor-mediated condition (2014-05-20),

13. 8618134 - Method and composition for treating a serotonin receptor-mediated condition (2013-12-31),

14. 8586610 - Methods for the administration of iloperidone (2013-11-19),

15. 7897355 - Gene expressed in prostate cancer and methods of use (2011-03-01),

Title: The Innovative Mind of Curt Douglas Wolfgang

Introduction

Curt Douglas Wolfgang, an accomplished inventor based in Germantown, MD, has made significant contributions to the field of psychiatry with a total of 18 patents. His work focuses primarily on the treatment of schizophrenia, showcasing his innovative approach to addressing complex psychiatric disorders.

Latest Patents

Among his notable inventions is a patent for Iloperidone, a promising treatment for schizophrenia. This invention highlights a method of preventing schizophrenic relapse by administering iloperidone or its metabolites at specific daily doses after a period of stabilization. In addition, Wolfgang has developed a patent related to an iloperidone metabolite, R-P88, designed for treating psychiatric disorders that respond to atypical antipsychotics. These advancements reflect his commitment to improving mental health treatments.

Career Highlights

Throughout his career, Wolfgang has been associated with prestigious organizations, including Vanda Pharmaceuticals Inc. and the United States of America, represented by the Secretary of the Department of Health and Human Services. His work in these institutions has allowed him to engage in cutting-edge research that directly impacts patient care in psychiatry.

Collaborations

Wolfgang's journey in the invention landscape has been enriched by collaborations with notable colleagues, including Mihael Hristos Polymeropoulos and Paolo Baroldi. These partnerships have fostered a productive environment for innovation and exploration of new therapeutic avenues in mental health.

Conclusion

Curt Douglas Wolfgang stands out as a remarkable inventor whose work has the potential to change the lives of individuals suffering from schizophrenia and other psychiatric disorders. With a robust portfolio of patents and a solid career trajectory, Wolfgang continues to be an influential figure in the field of psychiatry and pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.